Joana Correia

Exogenus Therapeutics

Bilateral Meetings

  • Wednesday 10:40 h – 13:00 h
  • Wednesday 14:00 h – 18:00 h
DescriptionExogenus Therapeutics (Exo-T) is a biotechnology company dedicated to pre-clinical and clinical development of advanced therapies for skin diseases. Exo-T envisage becoming a company of reference for the use of exosomes as a treatment tool for skin lesions, including wound healing. The company is presently developing its first product, Exo-Wound, which is derived from Umbilical Cord Blood for the treatment of chronic wounds, which affect millions of people worldwide.
Organization Type Company
Areas of Activities



    Wound healing animal testing

    We are looking for partners to develop experiments in animal models such as wound healing efficacy tests and GLP toxicology.

    Cooperation Offered
    1. Technical co-operation

    Wound Care licensing opportunity

    We are looking for pharma companies commercializing Wound Care products for future out licensing of our product or technology.

    Cooperation Offered
    1. License agreement

    Health - Life Sciences Investment

    We are looking for investors for the clinical development phase of our product.

    Cooperation Requested
    1. Investment/Financing

    Partners wanted: Biobanks aGMP-compliant production

    We are looking for biobanks working with Umbilical Cord Blood for research & development based in Europe or USA. We are also looking for GMP production contractors with experience in cell therapy.

    Cooperation Requested
    1. Manufacturing agreement